These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9186684)

  • 81. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hyper IgM syndrome: two mutations distinguish HIM.
    Foy TM; Masters SR; Noelle RJ
    J Clin Invest; 1994 Oct; 94(4):1349-50. PubMed ID: 7523448
    [No Abstract]   [Full Text] [Related]  

  • 84. Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergy.
    Min B; Legge KL; Bell JJ; Gregg RK; Li L; Caprio JC; Zaghouani H
    J Immunol; 2001 May; 166(9):5594-603. PubMed ID: 11313399
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.
    Lane P; Brocker T; Hubele S; Padovan E; Lanzavecchia A; McConnell F
    J Exp Med; 1993 Apr; 177(4):1209-13. PubMed ID: 7681469
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation.
    Kehry MR; Castle BE
    Semin Immunol; 1994 Oct; 6(5):287-94. PubMed ID: 7865800
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Editorial: (CD)40 winks to prevent CD8+ T cell lethargy.
    Bullock TN
    J Leukoc Biol; 2012 Jun; 91(6):845-8. PubMed ID: 22654123
    [No Abstract]   [Full Text] [Related]  

  • 88. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
    Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
    J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
    Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
    Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
    Oberwalleney G; Henz BM; Worm M
    Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
    [TBL] [Abstract][Full Text] [Related]  

  • 92. CD40-CD154 interaction in experimental and human disease (review).
    Biancone L; Cantaluppi V; Camussi G
    Int J Mol Med; 1999 Apr; 3(4):343-53. PubMed ID: 10085405
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The CD40 antigen and its ligand.
    Banchereau J; Bazan F; Blanchard D; Brière F; Galizzi JP; van Kooten C; Liu YJ; Rousset F; Saeland S
    Annu Rev Immunol; 1994; 12():881-922. PubMed ID: 7516669
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.
    Liang L; Porter EM; Sha WC
    J Exp Med; 2002 Jul; 196(1):97-108. PubMed ID: 12093874
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
    Clatza A; Bonifaz LC; Vignali DA; Moreno J
    J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells.
    Pound JD; Challa A; Holder MJ; Armitage RJ; Dower SK; Fanslow WC; Kikutani H; Paulie S; Gregory CD; Gordon J
    Int Immunol; 1999 Jan; 11(1):11-20. PubMed ID: 10050669
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antibody production in autoimmune BXSB mice. I. CD40L-expressing B cells need fewer signals for polyclonal antibody synthesis.
    Blossom S; Gilbert KM
    Clin Exp Immunol; 1999 Oct; 118(1):147-53. PubMed ID: 10540172
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
    Nishioka Y; Lipsky PE
    J Immunol; 1994 Aug; 153(3):1027-36. PubMed ID: 7517971
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dialysis and transplantation.
    Paul LC
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):665-8. PubMed ID: 10630810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.